Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works as a GLP-1 receptor agonist that slows stomach emptying and reduces appetite signals in your brain. Most clinical data shows the steepest weight loss curve happens in the middle months of therapy, not the beginning. Understanding this timeline helps you set realistic expectations and stay motivated through your treatment journey.

Weeks One Through Four: Initial Adjustment Phase

Your body begins responding to semaglutide immediately, but the weight loss during the first month is typically modest—often between one and three pounds. This lag happens because your dose starts low to let your system adapt, and your appetite suppression builds gradually over time. Many patients report feeling fuller faster during meals and experiencing reduced cravings within the first two weeks.

Nausea and mild digestive changes are common in week one and two as your gut adjusts to the medication's presence. These side effects usually fade by week three or four as your body acclimates. Staying hydrated, eating smaller portions, and choosing protein-rich foods can ease this transition period and support your emerging weight loss.

Months Two and Three: Dose Escalation and Acceleration

As your dose increases during month two and three, weight loss typically accelerates noticeably. Most people report dropping two to four pounds per week during this window, making it the first truly visible phase of progress. Your appetite suppression deepens, and many patients find that foods they previously enjoyed hold less appeal.

This acceleration phase is when you may notice changes in how clothes fit and when loved ones start commenting on your appearance. The rapid shift happens because higher doses trigger stronger GLP-1 receptor activation in your hypothalamus and in your gut's vagal nerves. Maintaining consistent protein intake and gentle movement helps preserve muscle mass while fat loss dominates.

Months Four Through Six: Maximum Weight Loss Window

The peak weight loss period for most semaglutide users occurs between month four and month six, when you reach your target maintenance dose. Clinical trials show average losses of three to five pounds per week during this window, with some individuals seeing even faster results. This is when the cumulative effect of appetite suppression, reduced calorie intake, and improved metabolic signaling creates the most dramatic body composition changes.

Month five and six represent the sweet spot where your dose is fully optimized and your behavioral changes have become more automatic. You may find yourself naturally choosing smaller portions and feeling satisfied with less food. This is also when genetic factors—like your GLP1R and GIPR sensitivity—begin to show their strongest influence on how effectively your body responds to the medication.

Months Seven Through Twelve: Plateau and Maintenance Transition

After month six, weight loss typically slows as your body reaches a new equilibrium weight. This is not a failure—it reflects your metabolism adapting to the lower calorie intake and the medication reaching steady-state effectiveness. You may still lose one to two pounds per week, but the rate is gentler than the peak months, and some weeks may show no scale change despite continued fat loss.

Months seven through twelve are when many patients shift their focus from rapid loss to establishing eating habits that maintain their new weight. Some people benefit from genetic testing, like PlexusDx Precision Peptide Genetic Test, to understand their individual peptide pathway sensitivities and optimize their long-term protocol. Continued consistency with movement, adequate protein, and stress management becomes more important as the medication's appetite-suppression effect stabilizes.

How Genetic Variation Affects Your Personal Timeline

Not everyone follows the same weight loss curve because genetic differences in GLP-1 receptor expression, FTO variants, and MC4R sensitivity influence how your body responds. Someone with higher GLP1R rs6923761 sensitivity may see faster results starting in month one, while others with different variants may experience their peak window in month five. PlexusDx Precision Peptide Genetic Test identifies your peptide-pathway profile across 49 key markers and 150+ insights to help predict your likely timeline.

Understanding your genetic predispositions allows PlexusDx providers to personalize your dose escalation and select between semaglutide, tirzepatide, or dual-compound protocols based on your individual receptor sensitivity. Patients who pursue genetic testing often report better alignment between their expectations and actual results, leading to higher treatment satisfaction and adherence through the plateau phase.

PlexusDx Compounded Semaglutide: Supporting Your Weight Loss Timeline

PlexusDx sources semaglutide from licensed 503A compounding pharmacies and delivers personalized injections starting at $149 monthly—no insurance required and no membership fees. Your dose may need to go up as your treatment progresses, but your price won't increase with dose escalation. This flat-rate pricing ensures you can afford the full optimization process from month one through your peak weight loss window without worrying about climbing costs.

Patients choosing PlexusDx compounded semaglutide gain access to a provider network that understands the month-by-month timeline and can adjust your protocol based on your individual response. HSA and FSA accounts are accepted, making treatment even more accessible. For those wanting deeper insight into their genetic peptide pathways, the Precision Peptide Genetic Test add-on ($99 after the first treatment month) maps your unique sensitivities and can refine expectations for your personal timeline.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why is my weight loss slower in month one than I expected?

Month one uses a starting dose designed for safety and tolerability, not maximum impact. Your appetite suppression and metabolic shift build gradually, so expect one to three pounds in week one through four. The faster weight loss arrives in months two through six as your dose increases and your body fully adapts.

What does clinical trial data show about semaglutide weight loss timing?

Landmark trials like STEP 1 and STEP 3 demonstrated that participants lost approximately 5-10% of starting body weight by month four, with continued losses through month twelve totaling 15-18% on average. The steepest descent occurred between months two and six, with plateauing afterward.

How does PlexusDx pricing work if I need dose increases throughout my timeline?

PlexusDx compounded semaglutide starts at $149 monthly with a flat rate across all commitment tiers. Your dose may increase as your timeline progresses, but your monthly price remains the same—no per-dose or dose-ladder pricing. This ensures predictable costs through your entire peak and plateau phases.

Is weight loss permanent after the peak months on semaglutide?

Weight loss is sustainable if you maintain the medication and the eating habits you've developed during treatment. Most people who continue semaglutide beyond month twelve maintain their results, though stopping the medication typically leads to gradual weight regain over months. This is why the behavioral changes during months four through six are so important.

Can genetic testing predict my personal weight loss timeline?

PlexusDx Precision Peptide Genetic Test analyzes variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to estimate your peptide-pathway responsiveness. While not a perfect predictor, these insights can suggest whether you're likely to experience earlier or later peak weight loss and whether semaglutide or tirzepatide may suit your genetics better.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves